Simon Miller - Mar 12, 2025 Form 4 Insider Report for EQUINIX INC (EQIX)

Signature
/s/ Samantha Lagocki, POA
Stock symbol
EQIX
Transactions as of
Mar 12, 2025
Transactions value $
-$216,521
Form type
4
Date filed
3/14/2025, 04:29 PM
Previous filing
Mar 12, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EQIX Common Stock Options Exercise $0 +257 +4.08% $0.00 6.56K Mar 12, 2025 Direct
transaction EQIX Common Stock Sale -$3.32K -4 -0.06% $830.63 6.56K Mar 13, 2025 Direct F1, F2
transaction EQIX Common Stock Sale -$11.7K -14 -0.21% $832.22 6.54K Mar 13, 2025 Direct F1, F3
transaction EQIX Common Stock Sale -$9.17K -11 -0.17% $833.33 6.53K Mar 13, 2025 Direct F1, F4
transaction EQIX Common Stock Sale -$22.5K -27 -0.41% $834.55 6.51K Mar 13, 2025 Direct F1, F5
transaction EQIX Common Stock Sale -$7.52K -9 -0.14% $835.38 6.5K Mar 13, 2025 Direct F1, F6
transaction EQIX Common Stock Sale -$10.9K -13 -0.2% $837.81 6.48K Mar 13, 2025 Direct F1, F7
transaction EQIX Common Stock Sale -$10.1K -12 -0.19% $838.57 6.47K Mar 13, 2025 Direct F1, F8
transaction EQIX Common Stock Sale -$6.73K -8 -0.12% $841.05 6.46K Mar 13, 2025 Direct F1, F9
transaction EQIX Common Stock Sale -$4.21K -5 -0.08% $841.90 6.46K Mar 13, 2025 Direct F1, F10
transaction EQIX Common Stock Sale -$11K -13 -0.2% $843.55 6.45K Mar 13, 2025 Direct F1, F11
transaction EQIX Common Stock Sale -$14.4K -17 -0.26% $844.71 6.43K Mar 13, 2025 Direct F1, F12
transaction EQIX Common Stock Sale -$18.6K -22 -0.34% $845.63 6.41K Mar 13, 2025 Direct F1, F13
transaction EQIX Common Stock Sale -$22.9K -27 -0.42% $846.66 6.38K Mar 13, 2025 Direct F1, F14
transaction EQIX Common Stock Sale -$29.7K -35 -0.55% $847.95 6.35K Mar 13, 2025 Direct F1, F15
transaction EQIX Common Stock Sale -$26.3K -31 -0.49% $848.97 6.31K Mar 13, 2025 Direct F1, F16
transaction EQIX Common Stock Sale -$7.65K -9 -0.14% $850.12 6.31K Mar 13, 2025 Direct F1, F17

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EQIX Restricted Stock Unit Award $0 +257 $0.00 257 Mar 12, 2025 Common Stock 257 $0.00 Direct F18, F19
transaction EQIX Restricted Stock Unit Options Exercise $0 -257 -100% $0.00 0 Mar 12, 2025 Common Stock 257 $0.00 Direct F18, F19
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 Trading Plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $830.37 to $830.92, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 17 to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $831.83 to $832.68 inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $833.08 to $834.035 inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $834.14 to $835.10 inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $835.17 to $835.92 inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $837.28 to $838.20 inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $838.33 to $839.125 inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $840.60 to $841.50 inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $841.75 to $842.225 inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $842.965 to $843.95 inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $844.00 to $845.00 inclusive.
F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $845.01 to $846.00 inclusive.
F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $846.26 to $847.22 inclusive.
F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $847.365 to $848.35 inclusive.
F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $848.41 to $849.31 inclusive.
F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $849.74 to $850.235 inclusive.
F18 Under the 2024 Annual Incentive Plan, subject to meeting performance criteria, the reporting person was eligible to receive a bonus to be paid in the form of fully-vested restricted stock units. The Compensation Committee has determined that the performance criteria were attained, and therefore 100% of the award was granted on March 12, 2025 as reported in this Form 4.
F19 Restricted stock unit award expires upon reporting person's termination of service.